BioCentury
ARTICLE | Clinical News

Remicade infliximab: Marketed

May 10, 1999 7:00 AM UTC

CNTO published in The New England Journal of Medicine previously reported results of its 94-patient Phase III trial of Remicade in Crohn's disease patients with fistulas (see BioCentury, Nov. 10, 1997...